ONO-7475 Phase I Study (ONO-7475-02)
Phase 1
Completed
- Conditions
- Solid tumors
- Registration Number
- JPRN-jRCT2080224028
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
1. Patients with histologically or cytologically confirmed advanced or metastatic solid tumors
2. ECOG Performance Status 0-1
3. Patients with life expectancy of at least 3 months
Exclusion Criteria
1. Patients with history of serious allergy
2. Patients with multiple cancers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method